NCT00434369View on ClinicalTrials.gov

5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

February 28, 2006

Conditions
Breast Cancer
Interventions
DRUG

CoFactor (ANX-510)

Trial Locations (6)

Unknown

Clinical Research Site in, Buenos Aires

Clinical Investigative Site, Acapulco

Clinical Investigative Site, Lima

Clinical Research Site in, Kazan'

Clinical Investigative Site, Saint Petersburg

Clinical Investigative Site, Valencia

Sponsors
All Listed Sponsors
lead

Mast Therapeutics, Inc.

INDUSTRY

NCT00434369 - 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients | Biotech Hunter | Biotech Hunter